| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Elizabeth P Lake, Brian G Mitchell, Darryl I Shorter, Thomas Kosten, Coreen B Domingo, Annette M Walde. Buprenorphine for the treatment of posttraumatic stress disorder. The American journal on addictions. vol 28. issue 2. 2020-01-31. PMID:30664299. |
the core pharmacological treatment of post-traumatic stress disorder (ptsd) is selective serotonin reuptake inhibitors (ssris), although remission is only around 30% with them. |
2020-01-31 |
2023-08-13 |
Not clear |
| Andrew C Naglich, Sara Bozeman, E Sherwood Brown, Bryon Adinof. Effect of Selective Serotonin Reuptake Inhibitors on Healthcare Utilization in Patients with Post-Traumatic Stress Disorder and Alcohol Use Disorder. Alcohol and alcoholism (Oxford, Oxfordshire). vol 54. issue 4. 2020-01-15. PMID:31185085. |
effect of selective serotonin reuptake inhibitors on healthcare utilization in patients with post-traumatic stress disorder and alcohol use disorder. |
2020-01-15 |
2023-08-13 |
Not clear |
| Andrew C Naglich, Sara Bozeman, E Sherwood Brown, Bryon Adinof. Effect of Selective Serotonin Reuptake Inhibitors on Healthcare Utilization in Patients with Post-Traumatic Stress Disorder and Alcohol Use Disorder. Alcohol and alcoholism (Oxford, Oxfordshire). vol 54. issue 4. 2020-01-15. PMID:31185085. |
the objective of this study is to address equivocation in estimates of selective serotonin reuptake inhibitor initiation (ssri) effect on all-cause and alcohol-related er visits, and medical or psychiatric admissions within 2 years of initial post-traumatic stress disorder (ptsd) diagnosis in patients with ptsd and alcohol use disorder (aud). |
2020-01-15 |
2023-08-13 |
Not clear |
| Kevin Sean Murnan. Serotonin 2A receptors are a stress response system: implications for post-traumatic stress disorder. Behavioural pharmacology. vol 30. issue 2 and 3-Spec Issue. 2020-01-06. PMID:30632995. |
serotonin 2a receptors are a stress response system: implications for post-traumatic stress disorder. |
2020-01-06 |
2023-08-13 |
Not clear |
| Soraya Seedat, Dan J. Stein, Robin A. Emsle. Open trial of citalopram in adults with post-traumatic stress disorder. The international journal of neuropsychopharmacology. vol 3. issue 2. 2019-11-20. PMID:11343590. |
the selective serotonin reuptake inhibitors (ssris) are rapidly emerging as preferred first-line drugs in the pharmacological management of post-traumatic stress disorder (ptsd). |
2019-11-20 |
2023-08-12 |
human |
| Pau Celada, M. Victoria Puig, Raúl Martín-Ruiz, Josep M. Casanovas, Francesc Artiga. Control of the serotonergic system by the medial prefrontal cortex: potential role in the etiology of PTSD and depressive disorders. Neurotoxicity research. vol 4. issue 5-6. 2019-11-20. PMID:12754155. |
thus, the abnormal prefrontal function in post-traumatic stress disorder and depressive patients may induce a disregulation of 5-ht neurons projecting to other brain areas that can underlie the existing symptomatology in these psychiatric disorders. |
2019-11-20 |
2023-08-12 |
Not clear |
| Hala Kerbage, Sami Rich. Non-Antidepressant Long-term Treatment in Post-Traumatic Stress Disorder (PTSD). Current clinical pharmacology. vol 10. issue 2. 2019-11-20. PMID:23438728. |
post-traumatic stress disorder (ptsd) is a frequent and disabling condition that occurs after exposure to a traumatic event, and selective serotonin reuptake inhibitors (ssris) are considered the first-line treatment approach for this disorder. |
2019-11-20 |
2023-08-12 |
Not clear |
| Caroline A Browne, Edgardo Falcon, Shivon A Robinson, Olivier Berton, Irwin Luck. Reversal of Stress-Induced Social Interaction Deficits by Buprenorphine. The international journal of neuropsychopharmacology. vol 21. issue 2. 2019-03-08. PMID:29020387. |
the avoidance of other rodents can be reversed by 28 days of treatment with selective serotonin reuptake inhibitors, the only pharmaceutical class approved by the u.s. food and drug administration for treating post-traumatic stress disorder. |
2019-03-08 |
2023-08-13 |
Not clear |
| Mingjun Xiang, Yuting Jiang, Zhiying Hu, Yang Yang, Benson O A Botchway, Marong Fan. Stimulation of Anxiety-Like Behavior via ERK Pathway by Competitive Serotonin Receptors 2A and 1A in Post-Traumatic Stress Disordered Mice. Neuro-Signals. vol 25. issue 1. 2019-03-05. PMID:28977803. |
serotonin 5ht2a and 5ht1a receptors (5ht2ar, 5ht1ar) have the closest connection to anxiety-like behavior in post-traumatic stress disorder (ptsd). |
2019-03-05 |
2023-08-13 |
mouse |
| Pieter Schipper, Marloes J A G Henckens, Dora Lopresto, Tamas Kozicz, Judith R Homber. Acute inescapable stress alleviates fear extinction recall deficits caused by serotonin transporter abolishment. Behavioural brain research. vol 346. 2018-09-11. PMID:29233642. |
life stress increases risk for developing post-traumatic stress disorder (ptsd), and more prominently so in short-allele carriers of the serotonin transporter linked polymorphic region (5-httlpr). |
2018-09-11 |
2023-08-13 |
Not clear |
| Lior Ariel, Sapir Inbar, Schachaf Edut, Gal Richter-Levi. Fluoxetine treatment is effective in a rat model of childhood-induced post-traumatic stress disorder. Translational psychiatry. vol 7. issue 11. 2018-07-10. PMID:29187754. |
although selective serotonin reuptake inhibitors (ssris) are first-line treatment for post-traumatic stress disorder (ptsd) patients, their therapeutic efficacy is limited. |
2018-07-10 |
2023-08-13 |
rat |
| Luiz Gustavo Schuch, Anita Yip, Kiana Farah Nouri, Maren Gregersen, Brian Cason, Jasleen Kukreja, Curtis Wozniak, Marek Brzezinsk. Serotonin Syndrome Following an Uncomplicated Orthopedic Surgery in a Patient With Post-Traumatic Stress Disorder. Military medicine. vol 181. issue 9. 2018-01-16. PMID:27612381. |
serotonin syndrome following an uncomplicated orthopedic surgery in a patient with post-traumatic stress disorder. |
2018-01-16 |
2023-08-13 |
Not clear |
| L Li, M X Li, L H Pan, G M Wang, M Guo, L Q Fu, J C Guo, Y S Gao, F Chen, M X Xi. Comparative analysis of platelet 5-HT concentrations in Han and Li patients with post-traumatic stress disorder. Genetics and molecular research : GMR. vol 15. issue 3. 2017-02-08. PMID:27525843. |
comparative analysis of platelet 5-ht concentrations in han and li patients with post-traumatic stress disorder. |
2017-02-08 |
2023-08-13 |
Not clear |
| L Li, M X Li, L H Pan, G M Wang, M Guo, L Q Fu, J C Guo, Y S Gao, F Chen, M X Xi. Comparative analysis of platelet 5-HT concentrations in Han and Li patients with post-traumatic stress disorder. Genetics and molecular research : GMR. vol 15. issue 3. 2017-02-08. PMID:27525843. |
we investigated the role of serotonin (5-ht) in the pathogenesis of post-traumatic stress disorder (ptsd) by determining the platelet 5-ht concentrations in li and han patients with ptsd in hainan province, china. |
2017-02-08 |
2023-08-13 |
Not clear |
| Basant Pradhan, Jessica Kluewer D'Amico, Ramkrishna Makani, Tapan Parik. Nonconventional interventions for chronic post-traumatic stress disorder: Ketamine, repetitive trans-cranial magnetic stimulation (rTMS), and alternative approaches. Journal of trauma & dissociation : the official journal of the International Society for the Study of Dissociation (ISSD). vol 17. issue 1. 2016-12-13. PMID:26162001. |
it is alarming that only 59% of those who have post-traumatic stress disorder (ptsd) respond to selective serotonin reuptake inhibitors. |
2016-12-13 |
2023-08-13 |
Not clear |
| Yassine Bentefour, Youness Rakibi, Mohamed Bennis, Saadia Ba-M'hamed, René Garci. Paroxetine treatment, following behavioral suppression of PTSD-like symptoms in mice, prevents relapse by activating the infralimbic cortex. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 26. issue 2. 2016-12-13. PMID:26706692. |
clinical studies have shown that post-traumatic stress disorder (ptsd) remission, induced by selective serotonin reuptake inhibitor (ssri) treatment, is associated with increased prefrontal activation during post-treatment symptom provocation. |
2016-12-13 |
2023-08-13 |
mouse |
| Jun-Cheng Guo, Zhi-Liang Tian, Xiao-Dan Wang, Min Guo, Meng-Yong-Wei Li, Yun-Suo Gao, Xiang-Ling Jiang, Lin-Mei Fu, Tao Huang, Xiang Li, Shu-Feng Yu, Li Yo. Post-traumatic stress disorder after typhoon disaster and its correlation with platelet 5-HT concentrations. Asian Pacific journal of tropical medicine. vol 9. issue 9. 2016-09-16. PMID:27633309. |
post-traumatic stress disorder after typhoon disaster and its correlation with platelet 5-ht concentrations. |
2016-09-16 |
2023-08-13 |
Not clear |
| Jun-Cheng Guo, Zhi-Liang Tian, Xiao-Dan Wang, Min Guo, Meng-Yong-Wei Li, Yun-Suo Gao, Xiang-Ling Jiang, Lin-Mei Fu, Tao Huang, Xiang Li, Shu-Feng Yu, Li Yo. Post-traumatic stress disorder after typhoon disaster and its correlation with platelet 5-HT concentrations. Asian Pacific journal of tropical medicine. vol 9. issue 9. 2016-09-16. PMID:27633309. |
to investigate residents' psychological stress factors and research the correlation between post-traumatic stress disorder (ptsd) and platelet 5-ht concentrations so as to provide scientific bases for diagnosis and treatment of ptsd and psychological intervention for people in the disaster area. |
2016-09-16 |
2023-08-13 |
Not clear |
| Russell J Lewis, Philip M Kemp, Robert D Johnso. Paroxetine in Postmortem Fluids and Tissues from Nine Aviation Accident Victims. Journal of analytical toxicology. vol 39. issue 8. 2016-09-09. PMID:26378138. |
paroxetine is a selective serotonin reuptake inhibitor commonly prescribed for the treatment of depression, obsessive-compulsive disorder, panic disorder, social anxiety disorder and post-traumatic stress disorder. |
2016-09-09 |
2023-08-13 |
Not clear |
| Jonathan Davidso. Vintage treatments for PTSD: a reconsideration of tricyclic drugs. Journal of psychopharmacology (Oxford, England). vol 29. issue 3. 2015-12-01. PMID:25586404. |
serotonin (ssri) and serotonin-norepinephrine (snri) reuptake inhibitors (ssri) are the first-line recommended drug treatments for post-traumatic stress disorder (ptsd); but despite their benefits, much residual pathology remains and no new drugs have yet emerged with a clearly demonstrated benefit for treating the disorder. |
2015-12-01 |
2023-08-13 |
Not clear |